Filana Therapeutics, Inc. (NASDAQ:FLNA) disclosed that its President and Chief Executive Officer, Barry Richard, acquired 440,206 shares of the company's common stock on November 16, 2026. The total value of the transactions was $206,896, according to a Form 4 filing signed by Eric J. Schoen by Power of Attorney on November 18, 2026.
The shares were purchased at a weighted average price of $0.47 per share, with individual transaction prices ranging from $0.45 to $0.48. The timing of the purchase proved fortuitous, as the stock has since surged over 50% in the past week to trade at $0.64. Despite this recent gain, the stock remains down 78% over the past year. According to InvestingPro analysis, the stock appears undervalued at current levels, with additional insights available through the platform's comprehensive Fair Value assessment and over 10 additional ProTips for FLNA investors.
Following these purchases, Mr. Richard indirectly beneficially owns 1,778,170 shares of Filana Therapeutics common stock through a trust.
In other recent developments, the United States Court of Appeals for the Fifth Circuit has vacated the class certification in a securities class action against Filana Therapeutics. This decision overturns a previous order by the U.S. District Court for the Western District of Texas. The appellate court agreed with Filana Therapeutics' position that the District Court misapplied the legal standard for certifying the class. Specifically, the court found that the evidence related to market inefficiency was not properly evaluated. Additionally, the Fifth Circuit noted that the District Court did not adequately consider the defendants' argument regarding meme-stock dynamics affecting the company's securities. This development was disclosed in a filing with the Securities and Exchange Commission.
These recent developments could impact the ongoing litigation against Filana Therapeutics. The stock closed at $0.6413 on November 20, up $0.0813 or 14.52%, and traded at $0.6277 after hours, down $0.0136 or 2.12%.